View abstract

This abstract is assigned to session 9 - DRUG DELIVERY AND EMERGING THERAPIES

Presentation preference	Invited lecture
Title	Inerleukin 17 inhibition - upcoming trial

Conflict of interest

No

Authors 1

Last name	NGUYEN
Initials of first name(s)	QD
City	Palo Alto
Country	United States